Unprecedented levels of cell-mediated immunity can be stimulated by the con
secutive use of DNA vaccines and attenuated poxvirus vectors encoding simil
ar heterologous antigens. This may offer a means of preventive vaccination
against diseases for which no effective treatment is available.